Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
First Bancorp
FBP
$4.41B
| $19.2M | 0.01% |
1,459,578
+278,361
| +24% | +$3.43M |
|
1352
Affirm
AFRM
$23.5B
| $19.2M | 0.01% |
161,070
-104,256
| -39% | -$8.33M |
|
|
PIAI
1353
DELISTED
Prime Impact Acquisition I
PIAI
| $19.1M | 0.01% |
1,949,431
| – | – |
|
1354
Rambus
RMBS
$8.98B
| $19.1M | 0.01% |
860,483
+557,270
| +184% | +$13.1M |
|
1355
GrafTech
EAF
$184M
| $19M | 0.01% |
184,441
-14,547
| -7% | -$1.59M |
|
1356
Corsair Gaming
CRSR
$1.1B
| $19M | 0.01% |
732,748
+696,987
| +1,949% | +$20M |
|
1357
Dave & Buster's
PLAY
$357M
| $19M | 0.01% |
495,040
+407,718
| +467% | +$14.7M |
|
1358
GameStop
GME
$9.8B
| $19M | 0.01% |
432,032
-274,952
| -39% | -$12.6M |
|
|
IIAC
1359
DELISTED
Investindustrial Acquisition Corp.
IIAC
| $18.9M | 0.01% |
1,908,073
+650,245
| +52% | +$6.44M |
|
1360
iShares MSCI Hong Kong ETF
EWH
$1.23B
| $18.9M | 0.01% |
789,650
+658,856
| +504% | +$17M |
|
|
AFTR.U
1361
DELISTED
AfterNext HealthTech Acquisition Corp Units
AFTR.U
| $18.9M | 0.01% |
+1,900,000
| New | +$18.9M |
|
1362
Varex Imaging
VREX
$462M
| $18.9M | 0.01% |
670,199
+367,932
| +122% | +$10.2M |
|
|
LGAC
1363
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $18.9M | 0.01% |
1,941,496
+204,315
| +12% | +$1.99M |
|
1364
CALL
Quest Diagnostics
DGX
$26B
| $18.9M | 0.01% |
130,000
+29,100
| +29% | +$4.26M |
|
1365
Dominion Energy
D
$62.1B
| $18.9M | 0.01% |
258,519
-949,652
| -79% | -$72.4M |
|
1366
Moog Inc Class A
MOG.A
$12.4B
| $18.9M | 0.01% |
247,413
+105,340
| +74% | +$8.23M |
|
1367
Sony
SONY
$137B
| $18.9M | 0.01% |
852,785
-670,515
| -44% | -$14M |
|
1368
CALL
Teleflex
TFX
$5.96B
| $18.8M | 0.01% |
50,000
+20,000
| +67% | +$7.79M |
|
1369
Oneok
OKE
$56.7B
| $18.8M | 0.01% |
324,559
-313,886
| -49% | -$16.9M |
|
1370
Standard BioTools
LAB
$342M
| $18.8M | 0.01% |
2,852,514
-530,143
| -16% | -$3.49M |
|
1371
CALL
Humana
HUM
$43.9B
| $18.8M | 0.01% |
48,300
+11,800
| +32% | +$5.01M |
|
1372
PUT
Martin Marietta Materials
MLM
$34.2B
| $18.8M | 0.01% |
55,000
+42,700
| +347% | +$15.5M |
|
1373
Herc Holdings
HRI
$4.78B
| $18.7M | 0.01% |
114,337
+40,532
| +55% | +$5.14M |
|
1374
CVR Energy
CVI
$3.48B
| $18.7M | 0.01% |
1,121,383
+174,477
| +18% | +$2.46M |
|
|
NARI
1375
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $18.7M | 0.01% |
230,081
-164,439
| -42% | -$13.8M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.